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Optical Mapping Of VF In Isolated Swine Hearts With Scars
Mihaela Pop1, Alan Soong2, JohnM. Hudson1, Paul Fefer1, Alexander Dick1,
Graham A. Wright1.
1University of Toronto, Toronto, ON, Canada, 2University of Waterloo,
Waterloo, ON, Canada.
Ventricular fibrillation (VF) is the main cause of sudden cardiac death. We hy-
pothesized that VF induced by large scars in an isolated porcine heart model
could aid the understanding of VF in human hearts associated with structural
disease. The explanted hearts were perfused with blood and Tyrode solution
at 37C, and optically imaged with a voltage-sensitive fluorescence dye (di4-
ANEPPS excited at 530nm with 150W halogen lamp). The emitted signal
was filtered (610nm) and recorded with high speed cameras (MiCAM02, Brain-
Vison, Jp) at 0.7mm spatial resolution. No optical signals could be recorded
from the core of chronic infarcts or RF lesions. A total of 10 hearts were
used: 4 controls, 3 with lesions generated via RF ablation and 3 with chronic
infarcts. We observed the propagation of the depolarization waves and ana-
lyzed the VF waveforms at the border zone (BZ) and normal myocardium.
We analyzed the VF waves in the frequency domain by calculating the domi-
nant frequency (DF) on select regions of interest using Matlab (Mathworks,
Ca). Our results showed that DF is smaller at the BZ compared to healthy tis-
sue. Referenced to the average DF in the control hearts (10.07þ/-0.54 Hz), the
DF was slightly smaller in healthy myocardium of infarct hearts (i.e., 8.9þ/
-0.71Hz) and significantly smaller at the border zone (i.e., 6.03 þ/- 0.86Hz).
In ablated hearts, mean DF in normal myocardium was 9.16þ/-0.7Hz and
7.24þ/-0.66Hz at BZ, respectively. We suggest that these differences are re-
lated to the heterogeneous restitution properties as well as the changes in tissue
structure at the BZ. The BZ of chronic scars is comprised of a mixture of viable
and necrotic fibers; whereas in the acute settings of RF lesions, inflammation
and edema are present at the BZ without alteration of fiber directions.
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Negative Regulation of LQT2-Associated Kv11.1 Mutant Channels by
Alpha(1A)-Adrenoceptors in Mammalian Cell Line
Dimitar P. Zankov1, Hidetada Yoshida2, Keiko Tsuji1, Futoshi Toyoda3,
Wei-Guang Ding3, Hiroshi Matsuura3, Minoru Horie1.
1Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan,
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Mutations in KCNH2 gene underlie type 2 of the congenital long-QT syndrome
(LQT2), in which rapid component of IK (IKr) is malfunctional and startled
auditory stimuli are specific symptomatic trigger. The latter suggests fast arrhyth-
mogenic mechanism. Therefore, we investigated acute alpha(1A)- and cAMP-
related beta-adrenergic modulation of IKr in HL-1 cardiomyocytes, wild type
(wt-) and two LQT2-associated mutant Kv11.1 channels (Kv11.1-Y43D and
Kv11.1-K595E) reconstituted in Chinese Hamster Ovary (CHO) cell line.
IKr and Kv11.1 currents were recorded through whole-cell patch-clamp tech-
nique and confocal microscopy of HL-1 cardiomyocytes transfected with
GFP-tagged pleckstrin homology domain of phospholipase C-delta(1), visual-
ized the fluctuations of membrane PIP2 content.
In HL-1 cardiomyocytes expressing human alpha(1A)-adrenoceptor, superfu-
sion with 30 micromol/l phenylephrine significantly reduced IKr amplitude,
shifted current activation to more positive potentials and accelerated kinetics
of deactivation. Confocal images demonstrated decline of PIP2 concentration
during phenylephrine exposure. Stimulation of beta(1)- and beta(2)-adrenocep-
tor downstream enzyme adenylyl cyclase by 5 micromol/l forskolin shifted
IKr activation to more negative potentials but did not significantly altered tail
current amplitude. In parallel, alpha(1A)-adrenoceptor activation downregulated
reconstituted wt-Kv11.1 channels but forskolin (5 micromol/l) produced little
effects. Expressed alone, Y43D-Kv11.1 or K595E-Kv11.1 channel had no mea-
surable function. However, co-expression of wt-Kv11.1 and each mutant
protein evoked currents with loss-of-function alterations but identical to
wt-Kv11.1 alpha(1A)- and forskolin-induced regulation.
Acute adrenergic regulation of at least two Kv11.1 mutant channels is pre-
served as in wt-Kv11.1 and native IKr and could have arrhythmogenic potential
in some LQT2 cases.
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The Role Of Mineralocorticoid Receptors In The Adaptation Of Cardiac
Myocytes To Pregnancy
Vale´rie Bassien-capsa1, Fathia Elzwiei1, Alzbeta Chorvatova1,2.
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Aim: Pregnancy is characterized by a hypertrophic remodeling of the heart, but
little is known about the role of hormonal regulation in this cardiac modifica-tion. Mineralocorticoid receptors (MRs) have been shown to mediate structural
and functional remodeling of the heart in pathological conditions. Also, its
agonists, glucocorticoids and mineralocorticoids, are significantly enhanced
in pregnancy. Our aim is therefore to examine the possible role of MRs in car-
diomyocyte adaptation during rat pregnancy. Methods: Pregnant rats were
studied one day before parturition. One group of pregnant rats (Pcan) was
treated with potassium canrenoate (20 mg/kg/day), a MRs antagonist, for the
last seven days of pregnancy, and compared to normal pregnant rats (P). These
groups were also compared to non-pregnant rats, treated (NPcan) or not treated
(NP). M-mode echocardiography was performed for the whole heart study.
Rapid video-imaging was used to record cell contractility at 0.5 Hz. Patch
clamp technique was applied to study L-type calcium currents (ICa-L). Re-
sults: MR antagonism in Pcan induced a decrease of the systolic and diastolic
dimensions of the heart, when compared to P. This result was corroborated by
a lower cell volume in Pcan. Cell contractility was not modified in all groups,
when glucose was the only energetic substrate. However, our results uncovered
a modified responsiveness to energetic substrates lactate and pyruvate, natu-
rally increased in the blood of P. Indeed, while cell contractility was raised
in P in the presence of these substrates, this effect was not observed in Pcan.
Interestingly, in Pcan, ICa-L tend to increase in the same energetic condition
when compared to ICa-L with glucose only. Conclusions: Our data indicate
that MRs are involved in the adaptation of cardiac myocytes to pregnancy at
the structural, metabolic, as well as functional level.
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The Sialyltransferase, ST3Gal-IV, Modulates Cardiac Action Potential
Waveforms And IK
Tara A. Schwetz, Marty L. Montpetit, Eric S. Bennett.
U. South Florida, College of Medicine, Tampa, FL, USA.
Atrial arrhythmias can be caused by changes in atrial action potential (AP)
waveform or conduction. The regulated activity of ion channels, including volt-
age-gated potassium (Kv) channel isoforms, is crucial to normal AP waveform.
Each Kv channel isoform is uniquely glycosylated; glycans are typically termi-
nated by sialic acid residues. Reports have shown sialic acids can modulate Kv
channel gating through isoform-specific mechanisms. Here, we questioned
whether regulated sialylation alters AP waveforms and voltage-gated Kþ cur-
rents (IK) produced in the atrium. AP waveform parameters and two types of
IK, the transient outward, Ito, and the slowly inactivating, IK,slow, were com-
pared in atrial myocytes isolated from neonatal control versus ST3Gal-IV
knockout animals. ST3Gal-IV is a sialyltransferase expressed at uniform levels
throughout the heart and adds sialic acid residues to N- and O-linked glycans
through a2-3 linkages. ECG recordings suggest that cardiac conduction/rhythm
are altered in ST3Gal-IV(-/-) animals. AP duration (APD) was prolonged signif-
icantly in ST3Gal-IV(-/-) atrial myocytes compared to control APD. APD10,
APD50, and APD90 values for ST3Gal-IV
(-/-) myocytes were ~50-80% greater
than control values (p<0.004). A reduction in Kv channel activity is one mech-
anism by which AP repolarization can be prolonged. To determine whether Kv
channel activity is modulated by ST3Gal-IV expression, whole cell IK from
control versus ST3Gal-IV(-/-) atrial myocytes were measured and compared.
The voltages of half-activation for Ito and IK,slow were shifted significantly by
>10 mV to more depolarized potentials in ST3Gal-IV(-/-) myocytes compared
to control (p < 0.001); a depolarizing shift in activation voltage will lead to
fewer Kv channels active at a membrane potential, effectively reducing Kv
channel activity. These data suggest that the regulated expression of a single
sialyltransferase, ST3Gal-IV, can alter IK, thus modulating the rate of atrial
repolarization and potentially leading to arrhythmias.
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Ion Channel Toolbox for Cardiac Safety Evaluation
Ruth L. Martin, James T. Limberis, Xiaoqin Liu, Kathryn A. Houseman,
Zhi Su, Gary A. Gintant, Bryan F. Cox.
Abbott Laboratories, Abbott Park, IL, USA.
The cardiac action potential is comprised of multiple ion channel currents act-
ing in concert and these ion channels are important in cardiac safety liability
assessment of potential drug candidates. Currently, hERG current screening
is a critical part of the preclinical assessment of a drug candidate and is required
before first in human (FIH) clinical studies. Through our ongoing efforts to pro-
vide efficient cardiac safety evaluation, while reducing animal usage, we have
incorporated the use of several cellular ion channel whole-cell voltage clamp
screens using heterologously expressed and native cardiac ion channels.
With heterologously expressing cell lines, the use of planar patch technology
(PatchXpress and QPatch) allows for moderate throughput by providing auto-
mated, simultaneous whole-cell voltage clamp recordings. In this study we
highlight five cardiac ion channels; 3 heterologously expressed cardiac potas-
sium channels (hERG [IKr], Kir2.1 [IK1], KvLQT1/minK [IKs]) that contribute
to the repolarization phase of the action potential and two additional cardiac ion
Monday, March 2, 2009 263achannels, whose primary contribution is to the upstroke and plateau of the action
potential; Nav1.5 [INa] (heterologously expressed) and the native cardiac L-type
Ca channel, Cav1.2 [ICaL] (cardiac myocytes). The biophysical properties of
these two cardiac ion channels have been extensively characterized and each
ion channel assay has been pharmacologically validated with reference com-
pounds. In conclusion, this approach is part of our continuing effort to move
to a cellular based in vitro safety approach to provide mechanistic SAR for solv-
ing cardiac safety issues. To date, our ion channel toolbox includes: hERG,
Kir2.1, KvLQT1/minK, Nav1.5 and the native cardiac L-type Ca channel
(Cav1.2); to be used on an as needed basis for cardiac safety evaluation.
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Do hERG Enhancers and Blockers Compete?
Xiaoqin Liu, James T. Limberis, Zhi Su, Kathryn A. Houseman,
Gilbert J. Diaz, Gary A. Gintant, Bryan F. Cox, Ruth L. Martin.
Abbott, Abbott park, IL, USA.
HERG (human ether a go-go related gene) encodes a cardiac potassium channel
that has been linked to delayed repolarization. Due to the large vestibule of the
hERG channel pore, many structurally dissimilar compounds are able to block
the hERG channel. This, along with specific requirement of hERG data by reg-
ulatory authorities, has added to the difficulty of drug discovery. Recently, we
have discovered a series of compounds (hACTs) that do not block hERG, but
actually enhance hERG current. hACT-1({4-[4-(5-trifluoromethyl-1H-pyrazol-
3-yl)-phenyl]-cyclohexyl}-acetic acid) enhanced hERG current by 50 % at
60 mM. In addition, hACT-1 caused concentration-dependent shortening of
the action potential duration in canine Purkinje fibers and guinea pig atrial tissue.
Preliminary studies suggest that binding of hACT-1 (60 mM) does not overlap
sites of typical hERG blockers. hACT-1 did not displace radio labeled dofeti-
lide. Also, in whole-cell voltage clamp studies, combination of hACT-1 with
known hERG blockers (i.e., sotalol and terfenadine) suggest that the com-
pounds are not competing for the same binding site. When applied simulta-
neously with a hERG blocker, the onset of hERG enhancement with hACT-1
occurs prior to block with either sotalol or terfenadine. Block with sotalol
(150 mM) occurs at the same magnitude when used alone (42 %), or in combi-
nation with hACT-1 (44 %). Similarly, the enhancement of hERG current by
hACT-1 is independent of sotalol block, just as the block of hERG current
by sotalol is independent of hACT-1 current enhancement. These effects dem-
onstrate that the binding site for enhanced hERG current is different than the
binding site for block.
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A Novel SCN5A Mutation Associated With Brugada Type ECG And
Intraventricular Conduction Defects
Kaveh Samani1, Tomohiko Ai1, Jeffrey A. Towbin2, Ramon Brugada3,
Yutao Xi1, Jie Cheng1, Matteo Vatta2.
1Texas Heart Institute/St Luke’s Episcopal Hospital, Houston, TX, USA,
2Pediatric Cardiology/Texas Children’s Hospital/Baylor College of
Medicine, Houston, TX, USA, 3Montreal Heart Institute, Montreal,
QC, Canada.
Background: Mutations of SCN5A, gene encoding a-subunit of cardiac
sodium channel, can cause mixed phenotypes of Brugada syndrome (BrS)
and cardiac conduction diseases (CCDs).
Methods: We have identified a novel nucleotide change of SCN5A (4178T>G)
which results in a nonsense mutation, L1393X, in a 36 year-old Caucasian male
who presented with intraventricular conduction delays and BrS type ECG
change. To study biophysical characteristics of L1393X-SCN5A, electrophys-
iological and immunostaining studies were performed using mammalian
expression systems.
Results: WhileWT-SCN5A showed significant currents (93.35 10.6 pA/pF; 1
mg plasmid), L1393X (5 mg) did not generate any significant currents in NIH-
3T3 cells. The cells co-transfected with WT (0.5 mg) and L1393X (0.5 mg)
showed approximately 50% current amplitudes compared to the WT (1 mg).
Voltage-dependency of the steady-state activation and inactivation was not
affected by the co-transfection of L1393X. Immunohistochemical stainings
demonstrated that L1393X proteins were expressed in the plasma membranes.
Conclusion: Our study demonstrated that L1393X-SCN5A does not form
functional channel proteins, which might account for the patient’s mixed
phenotypes of BrS and CCDs.
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Effects Of Silencing Synapse Associated Protein-97 On Cardiac Potassium
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Ravi Vaidyanathan1, Steven M. Taffet1, Karen L. Vikstrom2,
Justus M.B. Anumonwo2.
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Michigan, Ann Arbor, MI, USA.Introduction: Synapse associated protein-97 (SAP97) is a scaffolding protein
expressed in cardiac myocytes. Previous studies have suggested that SAP97 in-
teracts with and modifies properties of ion channels. We have investigated the
functional effect of silencing SAP97 on major repolarizing currents in adult rat
ventricular myocytes (ARVMs). Methods: SAP97 was silenced using a shRNA
expressing adenovirus. The standard patch clamp technique was used to inves-
tigate the effects of this silencing on potassium currents in ARVMs. Control
experiments were carried out in ARVMs infected with a GFP expressing ade-
novirus. Results: Western blot analysis showed that SAP97 was silenced in
ARVM after 3 days in culture. In SAP97 silenced ARVMs, IK1 density was
reduced by ~50% when measured at -100 mV (Holding potential (HP) ¼
-50 mV). Average current density was -1.8550.3 pA/pF, n¼12 as compared
to -3.7650.5 pA/pF, n ¼ 6 in control cells. Depolarization-activated (at
þ60 mV, HP ¼ -70 mV) currents in the ARVM were fitted with a two-expo-
nential function for analysis. Amplitude and kinetic analysis of the fits showed
that there was a 30% decrease in the current density of the first component in
SAP97 silenced ARVMs (951.9 pA/pF, n¼5) as compared to control
(13.550.9 pA/pF, n¼4). SAP97 silencing however did not significantly change
the kinetics of the first component. Time constants averaged 68512 msec and
1.150.1 sec in control versus 121524 msec and 1.4750.21 sec in SAP97 si-
lenced cells. Compared to the control cells, there was no change in the current
density of the second component in SAP97 silenced cells. Current amplitude
averaged 3.150.4 pA/pF (n¼5) and 3.750.2 pA/pF (n¼4), respectively for
SAP97 silenced ARVMs and control. These results suggest that the silencing
of SAP97 has differential effects on potassium currents in adult cardiac
myocytes.
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Evidence And Functional Impact Of A New Kþ Channel In Mouse
Ventricular Fibroblasts
Najate Benamer1, Hamid Moha ou maati1, Sophie Demolombe2,3,
Patrick Bois1, Jocelyn Bescond1, Jean-Franc¸ois Faivre1.
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In the heart, fibroblasts represent the major cell type. They contribute to the
production of the extracellular matrix. Cardiac remodelling during pathological
injury is associated with differenciation of fibroblasts into myofibroblasts. The
aim of this study was to characterize at molecular and functional levels a new
K conductance in these cells.
Among K channel transcripts which were screened by high-throughput real-
time PCR, SUR2 and Kir6.1 mRNAs were found to be the most abundant.
Western-blots showed that SUR2 and Kir6.1 protein expression levels in-
creased with culture duration as fibroblasts differenciated into myofibroblasts.
In the inside-out configuration of the patch-clamp technique, SUR2/Kir6.1
K channels were recorded and showed insensitivity to ATP, inhibition by gli-
benclamide and activation by pinacidil and UDP. These properties are similar
to those reported by Yamada et al (1998) for the SUR2/Kir6.1 molecular sig-
nature. In the whole cell configuration, these channels gave rise to a macro-
scopic glibenclamide-sensitive current which was activated by pinacidil and
which amplitude increased with culture duration. This current was also acti-
vated by the endogenous sphingolipid sphingosine-1-phosphate (S1P) at the
nM concentration range. The activation of this current was found to stimulate
cell proliferation and to decrease IL-6 secretion. All these functional effects
occurred for culture duration greater than 5 days.
In conclusion this work shows for the first time the presence of a glibenclamide-
sensitive current which appears during differenciation of fibroblasts into myo-
fibroblasts. This SUR2/Kir6.1 current, which may be activated in pathological
conditions where fibroblasts differentiate into myofibroblasts and where S1P
level increases, may modulate cardiac ventricular function.TRP Channels
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The TRP Domain Of TRPC3 Is Essential But Not Sufficient For Erythro-
poietin- Regulated Activation Of TRPC3
Iwona M. Hirschler-Laszkiewicz.
Penn State University, Hershey, PA, USA.
TRPC3 and TRPC6 are nonselective calcium channels and two members of
the canonical transient receptor potential (TRPC) subfamily expressed on
human erythroblasts. Although they are 73% identical in their amino acids
sequence, they respond differently to erythropoietin (Epo) stimulation. Epo
stimulates a significantly greater increase in calcium influx through TRPC3
(23657% increase above baseline) compared to TRPC6 (7455% above base-
line). TRPC6 also inhibits Epo-stimulated calcium influx in cells cotransfected
